Cited by 221Liver Disease and TransplantationNutrition and Health in AgingClinical Nutrition and Gastroenterology

Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list

Open access
Duarte‐Rojo, Andrés, Ruiz‐Margáin, Astrid, Montaño‐Loza, Aldo J., Macías‐Rodríguez, Ricardo U., Ferrando, Arny, Kim, W. Ray·2018·Liver Transplantation

Abstract

Sarcopenia and physical deconditioning are frequent complications in patients with cirrhosis and end-stage liver disease (ESLD). They are the end result of impaired dietary intake, chronic inflammation, altered macronutrient and micronutrient metabolism, and low physical activity. Frailty is the end result of prolonged sarcopenia and physical deconditioning. It severely affects a patient's functional status and presents in approximately 1 in 5 patients on the liver transplantation waiting list. Sarcopenia, poor physical fitness/cardiopulmonary endurance (CPE), and frailty are all associated with increased mortality in ESLD. Clinical trials addressing the usefulness of exercise in patients with cirrhosis have shown that it improves the metabolic syndrome, sarcopenia, CPE, health-related quality of life, and hepatic venous pressure gradient. Although evidence on the benefits of exercise on clinical outcomes derived from large clinical trials is still missing, based on existing literature from multiple medical subspecialties, we believe that an exercise program coupled to a tailored nutritional intervention benefits both cardiopulmonary and musculoskeletal functions, ultimately translating into improved functional status, sense of well-being, and possibly less complications from portal hypertension. In conclusion, although supervised exercise training is the prevailing approach to manage ESLD patients, such intervention is not sustainable or feasible for most patients. Innovative home-based physical activity interventions may be able to effectively reach a larger number of patients. Liver Transplantation 24 122-139 2018 AASLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/lt.24958

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RCTs in individuals with MASLD show that exercise improves quality of life, cardiorespiratory fitness, reduces visceral fat, and improves muscle mass and function even in advanced liver disease.

    “However, RCTs in individuals with MASLD show that exercise improves quality of life, cardiorespiratory fi tness, reduces visceral fat, and improves muscle mass and function even in advanced liver disease. 320,321”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [320]

    The exercise-intervention section reports randomized trials in patients with cirrhosis that found improvements in fitness, muscle measures, and some quality-of-life measures. It does not identify those trial participants as having MASLD; its reported visceral-fat improvement comes from a study in chronic hepatitis C. The Exercise Prescription in ESLD section says severely frail or sarcopenic patients had not been included in clinical trials, so the claim extends the trial findings too far into advanced disease. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA; for Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicen- ter study to define sarcopenia in patients with end-stage liver dis- ease. Liver Transpl 2017;23:625-633.
  2. ATS Committee on Proficiency Standards for Clinical Pulmo- nary Function Laboratories. ATS statement. Am J Respir Crit Care Med 2002;166:111-117.
  3. Merli M, Giusto M, Molfino A, Bonetto A, Rossi M, Ginanni Corradini S, et al. MuRF-1 and p-GSK3b expression in muscle atrophy of cirrhosis. Liver Int 2013;33:714-721.

Cited by

Sorted by citations

Authors
Duarte‐Rojo, A., Ruiz‐Margáin, A., Montaño‐Loza, A. J., Macías‐Rodríguez, R. U., Ferrando, A., & Kim, W. R.
Affiliations
  • Division of Gastroenterology and Hepatology
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
  • University of Alberta (CA)
  • University of Arkansas for Medical Sciences (US)
  • Stanford Medicine (US)
Corresponding author
Duarte‐Rojo, Andrés
Venue
Liver Transplantation
Published
2017-12-21
Volume
24
Issue
1
Pages
122-139
ISSN
  • 1527-6465 (ISSN-L)
  • 1527-6473
OpenAlex
W2796635101
Cited by
221
References
83
Citations by year
2026: 15 · 2025: 22 · 2024: 24 · 2023: 30 · 2022: 19 · 2021: 37 · 2020: 26 · 2019: 26 · 2018: 21
FWCI
12.32
Type
journal article
Language
en
Open access
Locations
  • Liver Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Gilead Sciences
  • Consejo Nacional de Ciencia y Tecnología
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
Keywords
exercise training, physical activity, end-stage liver disease, liver cirrhosis, sarcopenia, frailty, functional status, liver transplant waiting list, cardiorespiratory fitness, dietary intervention, home-based exercise, portal hypertension, chronic inflammation
MeSH terms
Exercise Therapy, Humans, Liver, Liver Cirrhosis, Nutritional Status, Physical Fitness, Quality of Life, Testosterone, Time Factors, Waiting Lists, Exercise, Liver Transplantation, Malnutrition, Anabolic Agents, Sarcopenia, End Stage Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review